SAN DIEGO, March 19 /PRNewswire-FirstCall/ — Imagenetix, Inc. (OTC Bulletin Board: IAGX – News), announced today that Director of Research and Development, Dr. Robert Hesslink, presented basic research outlining the cellular pathway instrumental in the efficacy of Celadrin®. Dr. Hesslink outlined the pathway before an audience of scientists and industry leaders at the Nutrigenomics 2008 [...]
{ Comments on this entry are closed }